-
Views
-
Cite
Cite
Supraja Laguduva Mohan, Manisha Jana, Early-onset Pompe disease: an imaging spectrum, QJM: An International Journal of Medicine, Volume 119, Issue 9, September 2026, Pages 739–741, https://doi.org/10.1093/qjmed/hcag067
Close - Share Icon Share
Abstract
Pompe disease is a glycogen storage disorder (type II) caused by a deficiency of the lysosomal enzyme acid maltase (also called alpha-glucosidase), resulting in the lysosomal accumulation of glycogen in multiple organs, predominantly the heart and skeletal muscle. In the early-onset type, the disorder is distinguished by severe hypotonia, macroglossia and hypertrophic cardiomyopathy, causing respiratory distress, feeding difficulty and death due to cardiorespiratory failure in the first year of life. The diagnosis is confirmed by enzyme testing, muscle biopsy or genetic testing. We report a case of early-onset Pompe disease in a 10-month-old infant with hypotonia, hypertrophic cardiomyopathy, macroglossia and enlarged and echogenic or hyperdense muscles on imaging.
- hypertrophic cardiomyopathy
- glycogen storage disease
- glycogen storage disease type ii
- alpha-glucosidase
- glucan 1,4-alpha-glucosidase
- glycogen
- infant
- skeletal muscles
- diagnosis
- diagnostic imaging
- enzymes
- heart
- congenital macroglossia
- muscle hypotonia
- genetic screening
- biopsy of muscle
- respiratory distress
- feeding difficulties
- gaa gene
- ultrasonographic echogenicity
- cardiorespiratory failure